Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 6, 2015, Pages

  Salam, Rehana A ^a   Das, Jai K ^a   Dojo Soeandy, Chesarahmia ^b   Lassi, Zohra S ^c   Bhutta, Zulfiqar A ^d  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; PLACEBO; INACTIVATED VACCINE;

CHILD DEATH; CONFIDENCE INTERVAL; DEVELOPING COUNTRY; EMERGENCY WARD; FETUS DISTRESS; GESTATIONAL AGE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HISPANIC; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT CARE; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INTUBATION; LOWEST INCOME GROUP; MATERNAL DEATH; MATERNAL MORTALITY; NEWBORN CARE; NEWBORN JAUNDICE; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; OUTPATIENT; PERINATAL DEATH; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; UNITED STATES; ADOLESCENT; ADULT; FEMALE; IMMUNOLOGY; INFLUENZA, HUMAN; META ANALYSIS; NEWBORN; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION;

ADOLESCENT; ADULT; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VACCINATION; VACCINES, INACTIVATED;

EID: 84957793143     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009982.pub2     Document Type: Review

References (64)

1. Glezen WP, Englund JA, Siber GR, Six HR, Turner C, Shriver D, et al. Maternal immunization with the capsular polysaccharide vaccine for haemophilus influenzae type b. Journal of Infectious Diseases 1992;165:134-6.
2. Madhi SA. Vaccination of HIV-uninfected pregnant women With trivalent influenza vaccine in the prevention of influenza illness during early infancy and in mothers: randomized controlled phase III trial evaluating safety, immunogenicity and efficacy. http://clinicaltrials.gov/ct2/show/record/NCT01306669 (accessed 29 June 2012).
3. Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants. New England Journal of Medicine 2014;371(10):918-31.
4. Englund JA, Glezen WP, Turner C, Harvey J, Thompson C, Siber GR. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate haemophilus influenzae type b vaccines. Journal of Infectious Diseases 1995;171(1):99-105.
5. Henkle E, Steinhoff MC, Omer SB, Roy OE, Arifeen SE, Raqib R, et al. Incidence of influenza infection in early infancy in Southern Asia. Pediatric Academic Societies' 2010 Annual Meeting; 2010 May 1-4; Vancouver, Canada. 2010.
6. Holmlund E, Nohynek H, Quiambao B, Ollgren J, Kayhty H. Mother-infant vaccination with pneumococcal polysaccharide vaccine: Persistence of maternal antibodies and responses of infants to vaccination. Vaccine 2011;29(28):4565-75.
7. Jackson LA, Patel SM, Swamy GK, Frey SE, Creech CB, Munoz FM, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. Journal of Infectious Diseases. 2011;204(6):854-63.
8. Madhi SA. Trivalent influenza vaccine in HIV-infected pregnant women and kinetics of transplacental anti-influenza antibody transfer and persistence in young infants: a randomized controlled phase II trial evaluating safety and immunogenicity. http://clinicaltrials.gov/show/NCT01306682 (accessed 29 June 2012).
9. Moniz M. Text messaging for preventative health during pregnancy; improving influenza vaccination rates in pregnancy: a randomized controlled trial of text messaging to increase vaccine uptake. http://clinicaltrials.gov/show/NCT01248520 (accessed 2012).
10. Mulholland K, Suara RO, Siber G, Roberton D, Jaffar S, N'Jie J. Maternal immunization with haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in the Gambia. International Journal of Gynecology & Obstetrics 1996;55:89-90.
11. Mulholland K, Suara RO, Siber G, Roberton D, Jaffar S, N'Jie J, et al. Maternal immunization with haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in the Gambia. JAMA 1996;275(15):1182-8.
12. Munoz FM, Englund JA, Cheesman CC, Maccato ML, Pinell PM, Nahm MH, et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 2001;20(6):826-37.
13. National Institute of Allergy and Infectious Diseases (NIAID). A phase II study in pregnant women to assess the safety and immunogenicity of an unadjuvanted Sanofi Pasteur H1N1 inactivated influenza vaccine administered at two dose levels. http://clinicaltrials.gov/ct2/show/record/NCT00963430 (accessed 2 July 2012).
14. Johnson R. Influenza vaccine in pregnant women. http://www.clinicaltrials.gov/ct2/show/NCT00905125 (accessed 10 March 2011).
15. National Institute of Allergy and Infectious Diseases (NIAID). A randomized, double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant women. http://clinicaltrials.gov/ct2/show/record/NCT00905125 (accessed 2 July 2012).
16. National Institute of Allergy and Infectious Diseases (NIAID). A phase II study in pregnant women to assess the safety and immunogenicity of an unadjuvanted Novartis H1N1 inactivated influenza vaccine administered at two dose levels. http://clinicaltrials.gov/show/NCT00992719 (accessed 2 July 2012).
17. National Institute of Allergy and Infectious Diseases (NIAID). 2010-2011 trivalent influenza vaccine (TIV) in pregnant women. http://clinicaltrials.gov/show/NCT01173211 (accessed 10 March 2011).
18. Omer SB, Zaman K, Roy E, Arifeen SE, Raqib R, Noory L, et al. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: Results from a randomized, blinded, controlled trial. Journal of Infectious Diseases 2013;207(7):1144-7.
19. Quiambao BP, Nohynek H, Kayhty H, Ollgren J, Gozum L, Gepanayao CP, et al. Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines. Vaccine 2003;21(24):3451-4.
20. Quiambao BP, Nohynek HM, Kayhty H, Ollgren JP, Gozum LS, Gepanayao CP, et al. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine 2007;25(22):4470-7.
21. Schlaudecker EP, Steinhoff MC, Omer SB, McNeal MM, Roy E, Arifeen SE, et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS ONE [Electronic Resource] 2013;8(8):e70867.
22. Stockwell MS, Westhoff C, Kharbanda EO, Vargas CY, Camargo S, Vawdrey DK, et al. Influenza vaccine text message reminders for urban, low-income pregnant women: a randomized controlled trial. American Journal of Public Health 2014;104(S1):e7-e12.
23. Tarrant M. A randomized controlled trial of a brief educational intervention to increase uptake of influenza vaccine among pregnant women. http://clinicaltrials.gov/ct2/show/NCT01772901 (accessed 21 May 2013).
24. Wong VW, Fong DY, Tarrant M. Brief education to increase uptake of influenza vaccine among pregnant women: a study protocol for a randomized controlled trial. BMC Pregnancy and Childbirth 2014;14:19.
25. Wootten SH. Opting in vs opting out: impact on influenza vaccination in pregnant women. http://clinicaltrials.gov/ct2/show/record/ 2012.
26. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Altaye M, et al. Influenza immunization in pregnancy and birth weights: observations from a randomised controlled trial. Pediatric Academic Societies' 2010 Annual Meeting; 2010 May 1-4; Vancouver, Canada. 2010.
27. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Dodd C, et al. Neonatal outcomes after influenza immunization during pregnancy: A randomised controlled trial. CMAJ: Canadian Medical Association journal 2012;184(6):645-53.
28. Steinhoff MC, Schlaudecker EP, Omer SB, Roy E, Altaye M, Zaman K. Antibody persistence in young adults one year after pneumococcal immunization in pregnancy. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2011 April 30-May 3; Denver, Colorado, USA. 2011.
29. Steinhoff MC, Schlaudecker EP, Omer SB, Roy E, Zaman K. Influenza IgA antibody in human milk: a randomised trial of maternal influenza immunization. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2011 April 30-May 3; Denver, Colorado, USA. 2011.
30. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. New England Journal of Medicine 2008;359(15):1555-64.
31. Garcia LG. Clinical trial to evaluate the immunogenicity and safety of the 2011-2012 vaccine against seasonal influenza on pregnant women. http://clinicaltrials.gov/ct2/show/record/NCT01577316 (accessed 29 June 2012).
32. Tapia MD. Prospective, randomized, controlled, observer-blind trial to measure the efficacy, safety and immunogenicity of trivalent inactivated influenza vaccine and the safety and immunogenicity of quadrivalent meningococcal polysaccharide diphtheria conjugate vaccine in pregnant Malian women and their infants up to 6 months of age. http://clinicaltrials.gov/show/NCT01430689 (accessed 29 June 2012).
33. Acs N, Banhidy F, Puho E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Research. Part A, Clinical and Molecular Teratology 2005;73:989-96.
34. Amstey MS, Insel R, Munoz J, Pichichero M. Fetal-neonatal passive immunization against Hemophilus influenzae, type b. American Journal of Obstetrics and Gynecology 1985;153(6):607-11.
35. Anderson P, Smith DH, Ingram DL, Wilkins J, Wehrle F, Howie VM. Antibody to polyribophosphate of Haemophilus influenzae type b in infants and children: effect of immunization with polyribophosphate. Journal of Infectious Diseases 1977;136:S57-S62.
36. Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D, et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. American Journal of Perinatology 2004;21(6):333-9.
37. Bridges CB, Woods MDL, Coyne-Beasley T. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older-United States, 2013. Morbidity and Mortality Weekly Report. Surveillance Summaries: MMWR 2013;62(Suppl 1):9-19.
38. Chaithongwongwatthana S, Yamasmit W, Limpongsanurak S, Lumbiganon P, DeSimone JA, Baxter JK, et al. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD004903.pub2]
39. Deinard AS, Ogburn P Jr. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. American Journal of Obstetrics and Gynecology 1981;140:240-5.
40. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. Journal of Infectious Diseases 1993;168(3):647-56.
41. France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Archives of Pediatrics and Adolescent Medicine 2006;160(12):1277-83.
42. Gilbert-Barness E. Teratogenic causes of malformations. Annals of Clinical & Laboratory Science 2010;40:99-114.
43. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatric Infectious Disease Journal 1997;16(11):1065-8.
44. McMaster University. GRADEpro [Computer program on www.gradepro.org]. 2015. McMaster University, 2014.
45. Hartert TV, Neuzil KM, Shintani AK, Mitchel EF Jr, Snowden MS, Wood LB, et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. American Journal of Obstetrics and Gynecology 2003;189(6):1705-12.
46. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
47. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. New England Journal of Medicine 2000;342(4):232-9.
48. Lindsay L, Jackson LA, Savitz DA, Weber DJ, Koch GG, Kong L, et al. Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women. American Journal of Epidemiology 2006;163(9):838-48.
49. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infectious Diseases 2008;8(1):44-52.
50. Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, et al. Influenza virus infection in infancy and early childhood. Paediatric Respiratory Reviews 2003;4(2):99-104.
51. Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, et al. Safety of influenza vaccination during pregnancy. American Journal of Obstetrics and Gynecology 2005;192(4):1098-106.
52. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. American Journal of Epidemiology 1998;148(11):1094-102.
53. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. Journal of Infectious Diseases 1980;142(6):844-9.
54. Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatric Infectious Disease Journal 1987;6(4):398-403.
55. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
56. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bulletin of the World Health Organization 2004;82:895-903.
57. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bulletin of the World Health Organization 2008;86:408-16.
58. Salam RA, Das JK, Bhutta ZA. Impact of haemophilus influenza type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD009982]
59. Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, et al. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatric Infectious Disease Journal 2001;20(10):931-40.
60. Schunemann HJ. GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2009;103(6):391-400.
61. Shi L, Tu N, Patterson PH. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. International Journal of Developmental Neuroscience 2005;23:299-305.
62. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. Journal of Infectious Diseases 1979;140(2):141-6.
63. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381(9875):1405-16.
64. WHO Haemophilus influenzae type B (HiB). http://www.who.int/mediacentre/factsheets/fs294/en/index.html (accessed 2012) 2005.